Systematic Reviews
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Jul 27, 2023; 15(7): 1501-1511
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1501
Table 1 Included studies listed according to year of publication
Study No.
Ref.
Period
Type of surgery
No. of trocars
M/F
Age
1Yao et al[14], 20142009-2013RP_LDP10/1138 ± 14.5
2Han et al [15], 20142007-2013MP_LDP-11/1749.1 ± 15.81
RP_LDP12/1061.3 ± 17.21
3Machado et al[16], 20152012-2014RP_LDP18/1244.6 ± 13.4
4Kim et al[17], 20172015-2016RDP_SS+122/337 ± 14.7
5Sumer et al[18], 20172006-2013MP_LDP47/2049.5 ± 14.9
RP_LDP10/354.3 ± 13.6
6Ağcaoğlu et al[19], 20192007-2014MP_LDP53/748.2 ± 4.0
RP_LDP14/643.5 ± 2.3
7Park et al[20], 20192012-2017MP_LDP4.4 ± 0.831/4455.3 ± 14
MP_LDP (propensity score matched)4.3 ± 0.59/1755.2 ± 15.3
RP_LDP19/1760.0 ± 17.4
8Kim et al[21], 20192015-2018MP_LDP4.9 ± 0.38/1855.3 ± 15.1
RP_LDP2.7 ± 0.75/1751.5 ± 17
9Han et al[22], 20192012-2018RP_LDP1.1 ± 0.28/1458.3 ± 15.01
RDP_SS+12.0 ± 0.73/1046.1 ± 14.01
10Park et al[23], 20202015-2018RDP_SS+125/2247.3
Table 2 Included studies listed by type of surgery
Type
Study No.
BMI
OP time (min)
Blood loss (mL)
Tumor size (cm)
SP rate (%)
Complication rate (%)
Hospital stay (d)
Follow-up duration (mo)
Ref.
POPF
Others
MP_LDP223.6 ± 4.0186.9 ± 86.61334 ± 4683.4 ± 2.5 60.721.4258.3 ± 4.71-[15]
5-163.3 ± 53.7--48.122.214.89.3 ± 6.630 ± 22.3[18]
631.2 ± 2.4116.4 ± 14.11110 (25-250)2.8 ± 0.65030101056[19]
725.4 ± 4.3182.6 ± 64.41210 ± 3843.1 ± 1.953.82041.913.2 ± 9.427.4 ± 22.3[20]
7 (propensity score matched)22.9 ± 2.9178.7 ± 66.61114 ± 18112.7 ± 2.35611.53611.6 ± 8.830.6 ± 24.7[20]
824.7 ± 2.6190.9 ± 43.71282.7 ± 305.313.6 ± 2.165.4--8.0 ± 1.4-[21]
RP_LDP122.67 ± 1.9163.18 ± 63.18159.09 ± 181.023.85 ± 1.2654.59.107.45 ± 1.4425.8 ± 18.1[14]
223.5 ± 4.6279.8 ± 53.01185 ± 1253.8 ± 1.833.32541.612.2 ± 5.41-[15]
3-176.2 ± 59.677.5 ± 55.03.2902002.1 ± 1.211[16]
5-216.7 ± 100.2--066.633.313 ± 14.913 ± 1.7[18]
629.4 ± 3.1180.4 ± 34.51142 (30-500)2.2 ± 0.2103020848[19]
723.6 ± 3.4278.9 ± 51.81205 ± 19713.3 ± 2.046.223.142.315.2 ± 11.420.8 ± 16.6[20]
825.2 ± 4.5119.3 ± 50.4196.8 ± 165.312.7 ± 1.895.5--7.7 ± 1.3-[21]
923.9 ± 3.6281 ± 521163 ± 19713.0 ± 1.854.518.236.414.4 ± 12.3123.4 ± 18.61[22]
RDP_SS+14-203 ± 73.311 ± 21.9-400-6.8 ± 1.3-[17]
920.9 ± 4.0192 ± 69112 ± 2212.7 ± 1.27.7038.57.4 ± 1.917.8 ± 7.11[22]
1022.617350334.6233.87-[23]
Table 3 Postoperative pain scores (only reported in five of the ten studies included)
Type
Study No.
Trocar No.
Postoperative pain score
Ref.
6 h
Day 1
Day 2
Day 3
Day 5
MP_LDP654.5 ± 0.411.5 ± 0.5[19]
74.4 ± 0.83.4 ± 1.113.4 ± 1.113.1 ± 0.91[20]
7 (propensity score matched)4.3 ± 0.53.5 ± 0.913.3 ± 0.913.0 ± 0.91[20]
84.9 ± 0.33.2 ± 1.43.5 ± 1.82.6 ± 1.31[21]
RP_LDP612.5 ± 0.311 ± 0.2[19]
712.7 ± 0.812.5 ± 1.312.4 ± 1.41[20]
82.7 ± 0.73.1 ± 1.12.8 ± 1.31.8 ± 0.91[21]
91.1 ± 0.22.6 ± 0.92.3 ± 1.5[22]
RDP_SS+192.0 ± 0.72.3 ± 1.22.5 ± 1.9[22]
102322[23]
Table 4 Average of the means and average of the standard deviations for age, body mass index, operating time, blood loss, tumor size, spleen preservation rate, complication rate, hospital stay, and follow-up duration for multi-port laparoscopic distal pancreatectomy, reduced-port laparoscopic distal pancreatectomy, and robotic distal pancreatectomy with single-site plus one-port
Type

MP_LDP
RP_LDP
RDP_SS+1
Age51.5 ± 14.351.4 ± 15.343.5 ± 14.2
BMI26.2 ± 3.924.7 ± 3.721.8 ± 4
Operation time (min)168 ± 62.7211.9 ± 54.2189.3 ± 70.1
Blood loss (mL)234.2 ± 389.9146.9 ± 165.124.3 ± 22
Tumor size (cm)3.2 ± 23.2 ± 1.72.9 ± 1.2
Spleen preservation rate (%)55.6 ± 7.348 ± 3427.4 ± 17.3
Complication rate (%)POPF23.4 ± 4.527.4 ± 18.47.7 ± 13.3
Others23.0 ± 14.124.8 ± 18.521.2 ± 24.5
Hospital stay (d)9.8 ± 7.410 ± 8.27.1 ± 1.8
Follow-up duration (mo)37.8 ± 22.323.7 ± 17.37.8 ± 7.1